SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-029467
Filing Date
2022-08-12
Accepted
2022-08-12 17:02:54
Documents
14
Period of Report
2022-08-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20003153x19_8k.htm   iXBRL 8-K 46355
2 EXHIBIT 99.1 ny20003153x19_ex99-1.htm EX-99.1 117511
3 EXHIBIT 99.2 ny20003153x19_ex99-2.htm EX-99.2 740424
  Complete submission text file 0001140361-22-029467.txt   1108428

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA neog-20220812.xsd EX-101.SCH 3859
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20220812_lab.xml EX-101.LAB 22546
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20220812_pre.xml EX-101.PRE 16040
8 EXTRACTED XBRL INSTANCE DOCUMENT ny20003153x19_8k_htm.xml XML 4051
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

IRS No.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 221161087
SIC: 2835 In Vitro & In Vivo Diagnostic Substances